Crossmark Global Holdings Inc. trimmed its position in Aetna Inc (NYSE:AET) by 9.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 28,775 shares of the company’s stock after selling 2,907 shares during the period. Crossmark Global Holdings Inc.’s holdings in Aetna were worth $5,837,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently made changes to their positions in AET. Cornerstone Wealth Management LLC raised its holdings in Aetna by 19,750.5% in the second quarter. Cornerstone Wealth Management LLC now owns 270,562 shares of the company’s stock valued at $1,457,000 after acquiring an additional 269,199 shares in the last quarter. Steward Partners Investment Advisory LLC raised its holdings in Aetna by 53.0% in the second quarter. Steward Partners Investment Advisory LLC now owns 4,104 shares of the company’s stock valued at $753,000 after acquiring an additional 1,421 shares in the last quarter. Sumitomo Life Insurance Co. raised its holdings in Aetna by 4.2% in the second quarter. Sumitomo Life Insurance Co. now owns 10,871 shares of the company’s stock valued at $1,995,000 after acquiring an additional 437 shares in the last quarter. Perella Weinberg Partners Capital Management LP raised its holdings in Aetna by 3.9% in the second quarter. Perella Weinberg Partners Capital Management LP now owns 121,367 shares of the company’s stock valued at $22,271,000 after acquiring an additional 4,510 shares in the last quarter. Finally, Harvest Management LLC raised its holdings in Aetna by 12.1% in the second quarter. Harvest Management LLC now owns 65,000 shares of the company’s stock valued at $11,928,000 after acquiring an additional 7,000 shares in the last quarter. Institutional investors own 82.34% of the company’s stock.

AET stock opened at $207.49 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.79 and a current ratio of 0.79. Aetna Inc has a twelve month low of $166.88 and a twelve month high of $210.90. The company has a market cap of $68.43 billion, a price-to-earnings ratio of 21.04, a P/E/G ratio of 1.77 and a beta of 0.71.

Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, October 30th. The company reported $2.96 earnings per share for the quarter, topping analysts’ consensus estimates of $2.83 by $0.13. Aetna had a net margin of 5.99% and a return on equity of 20.78%. The company had revenue of $15.48 billion for the quarter, compared to analysts’ expectations of $15.40 billion. During the same quarter last year, the company earned $2.45 earnings per share. The firm’s revenue for the quarter was up 3.3% on a year-over-year basis. As a group, analysts predict that Aetna Inc will post 11.38 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 0.96%. Aetna’s payout ratio is currently 20.28%.

Several brokerages recently weighed in on AET. Zacks Investment Research reaffirmed a “buy” rating and issued a $224.00 target price on shares of Aetna in a report on Monday, November 12th. Citigroup raised their target price on shares of Aetna from $202.00 to $206.00 and gave the company a “neutral” rating in a report on Wednesday, October 31st. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $202.00 target price on shares of Aetna in a report on Thursday, August 2nd. Credit Suisse Group raised their target price on shares of Aetna from $202.00 to $207.00 and gave the company a “neutral” rating in a report on Monday, October 22nd. Finally, Piper Jaffray Companies cut shares of Aetna from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $212.00 to $206.00 in a report on Tuesday, October 30th. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $204.18.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/11/20/aetna-inc-aet-holdings-trimmed-by-crossmark-global-holdings-inc.html.

About Aetna

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Recommended Story: What is intrinsic value?

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.